Clinical and metabolic parameters associated with time in ranges and glucose variability in patients with type 2 diabetes treated with insulin

Poster (download)

458

Julia F. Semenova1, Maksim V. Dashkin2, Olga N. Fazullina3
1Laboratory of Endocrinology Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences(RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, ekmxtyjr@yandex.ru
2Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, mdashkin@invitro.ru
3Laboratory of Endocrinology Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences(RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, fazullina@ngs.ru

Background and aim: Continuous glucose monitoring (CGM) provides an excellent opportunity for in-depth assessment of glycemic control and glucose variability (GV) in diabetic subjects. The aim of our study was to determine the clinical and metabolic parameters associated with non-targeted time in range (TIR) increased GV in patients with type 2 diabetes (T2D) treated with insulin.В Materials and Methods: One hundred and thirty six insulin-treated patients with T2D were included. Real-time or blinded CGM was performed using Medtronic CGM devices. The TIR and Mean Amplitude of Glucose Excursion (MAGE) were estimated. The advance glycation end-products (AGEs) levels were measured in blood serum by ELISA.В Results: Patients with non-targeted TIR (>70%) had higher glycated hemoglobin HbA1c, triglycerides and proteinuria as compared to those with targeted TIR. Urinary albumin-to-creatinine ratio tended to be higher in patients with non-targeted TIR also. Patients with higher MAGE (>4.5 mmol/l) demonstrated lower levels of triglycerides and uric acid and increased AGEs levels as compared to those with MAGE <4.5 mmol/l.В Conclusions: In T2D subjects, non-targeted TIR is associated with hypertriglyceridemia and proteinuria, meantime, increased MAGE is related to lower serum levels of triglycerides and uric acid and higher levels of AGEs.

 

0 0 votes
Article Rating
Subscribe
Notify of
guest
20 Comments
Inline Feedbacks
View all comments
Shumkov Oleg
Shumkov Oleg
4 years ago

Is continuous glucose monitoring a sought-after procedure for surgical patients preparing for amputation of extremity?
Thank you for your report.

Julia F. Semenova |
Julia F. Semenova |
4 years ago
Reply to  Shumkov Oleg

Thanks for your question. A differentiated approach to the conduct of CGM is required. If the patient is not compensated, there is a suspicion of episodes of latent hypoglycemia, the conduct of CGM is necessary in this case.

trackback

… [Trackback]

[…] Read More on to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] There you will find 90479 additional Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
3 months ago

Clinical and metabolic parameters associated with time in ranges and glucose variability in patients with type 2 diabetes treated with insulin

http://www.vaticanhistory.de/wordpress/?p=11782

trackback
2 months ago

… [Trackback]

[…] There you will find 9093 more Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Read More here to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
2 months ago

… [Trackback]

[…] Read More here to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
2 months ago

… [Trackback]

[…] Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Info on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Read More on on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
KC9
1 month ago

… [Trackback]

[…] Find More to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
1 month ago

… [Trackback]

[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Read More Info here on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Read More on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] Find More to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback
8 days ago

… [Trackback]

[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]

trackback

… [Trackback]

[…] There you will find 67007 more Info on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]